Astera Labs (NASDAQ:ALAB) General Counsel Philip Mazzara Sells 10,000 Shares

Key Points

• Philip Mazzara, General Counsel of Astera Labs, sold 10,000 shares of the company's stock for a total of $1,887,000, reducing his ownership by 5.83% to 161,573 shares.
• Astera Labs recently reported a strong quarterly performance, with $0.44 earnings per share and revenues up 149.5% year-over-year, exceeding analyst expectations.
• Analysts maintain a positive outlook on Astera Labs, with several upgrades, including target price changes ranging from $145.00 to $215.00 and a large majority rating the stock as either "Buy" or "Strong Buy."

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) General Counsel Philip Mazzara sold 10,000 shares of the firm's stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $188.70, for a total transaction of $1,887,000.00. Following the completion of the transaction, the general counsel directly owned 161,573 shares in the company, valued at approximately $30,488,825.10. The trade was a 5.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Philip Mazzara also recently made the following trade(s):

• On Monday, August 18th, Philip Mazzara sold 7,237 shares of Astera Labs stock. The stock was sold at an average price of $183.51, for a total transaction of $1,328,061.87.

Astera Labs Price Performance

Shares of NASDAQ ALAB traded down $7.96 during midday trading on Tuesday, reaching $174.24. 5,811,711 shares of the stock were exchanged, compared to its average volume of 5,376,900. The company has a market capitalization of $28.96 billion, a price-to-earnings ratio of 311.14, a P/E/G ratio of 4.62 and a beta of 1.48. Astera Labs, Inc. has a 12 month low of $36.85 and a 12 month high of $199.47. The business has a 50-day simple moving average of $136.10 and a two-hundred day simple moving average of $96.96.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The firm had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company's revenue was up 149.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently commented on the stock. CICC Research assumed coverage on shares of Astera Labs in a report on Friday. They set an "outperform" rating and a $190.00 target price for the company. Evercore ISI upped their price target on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, August 6th. Zacks Research raised shares of Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. Stifel Nicolaus set a $145.00 price target on shares of Astera Labs and gave the company a "buy" rating in a research note on Monday, August 4th. Finally, Barclays reiterated an "overweight" rating and issued a $155.00 target price (up from $75.00) on shares of Astera Labs in a report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $142.00.

Institutional Trading of Astera Labs

Several hedge funds have recently added to or reduced their stakes in the stock. Oliver Lagore Vanvalin Investment Group purchased a new position in Astera Labs in the 2nd quarter worth approximately $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs during the 2nd quarter valued at $36,000. Clearstead Trust LLC raised its holdings in Astera Labs by 46,100.0% in the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company's stock worth $42,000 after purchasing an additional 461 shares in the last quarter. Advisors Asset Management Inc. raised its holdings in Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company's stock worth $43,000 after purchasing an additional 194 shares in the last quarter. Finally, Manchester Capital Management LLC raised its holdings in Astera Labs by 141.5% in the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company's stock worth $44,000 after purchasing an additional 283 shares in the last quarter. Institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.